Experimental animal models of encapsulating peritoneal sclerosis

Area of Science:

• Nephrology
• Pathology
• Animal Modeling

Background:

• Encapsulating peritoneal sclerosis (EPS) is a rare but severe complication of long-term peritoneal dialysis.
• The multifactorial causes of EPS are not fully understood, necessitating further research into its developmental pathways and predictive markers.

Purpose of the Study:

• To review the utility of animal models in understanding EPS development and progression.
• To identify potential therapeutic strategies and predictive markers for EPS.

Main Methods:

• Review of rodent models utilizing chronic chemical irritation to induce peritoneal sclerosis and abdominal encapsulation.
• Analysis of pathological findings in animal models, including inflammation, fibrosis, and membrane damage.
• Evaluation of therapeutic interventions tested in animal models, such as anti-inflammatory, antifibrotic, and renin-angiotensin system inhibitors.

Main Results:

• Rodent models mimic key pathological features of clinical EPS, including inflammation, fibrosis, and cocoon formation.
• Therapeutic agents like anti-inflammatory drugs and renin-angiotensin system inhibitors show potential in blocking disease progression in these models.
• Current models primarily use chemical irritants, highlighting the need for models incorporating clinical risk factors.

Conclusions:

• Animal models are crucial for elucidating EPS pathogenesis, identifying biomarkers, and testing interventions.
• Future research should focus on developing clinically relevant animal models incorporating factors like uremia, peritonitis, and dialysis solution exposure.
• These advanced models will facilitate the identification and management of high-risk patients.